BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26903606)

  • 1. Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells.
    Vieira AP; Trindade MÂ; Pagliari C; Avancini J; Sakai-Valente NY; Duarte AJ; Benard G
    Am J Trop Med Hyg; 2016 Apr; 94(4):721-7. PubMed ID: 26903606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions.
    Costa MB; Hungria EM; Freitas AA; Sousa ALOM; Jampietro J; Soares FA; Stefani MMA
    PLoS One; 2018; 13(6):e0196853. PubMed ID: 29883464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
    Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
    Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 and IL-23 modulate plasticity of FoxP3
    Tarique M; Saini C; Naqvi RA; Khanna N; Sharma A; Rao DN
    Mol Immunol; 2017 Mar; 83():72-81. PubMed ID: 28110210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 plays an important role in modulating "Th17-Treg" cell axis in leprosy Type 1 reactions.
    Saini C; Sapra L; Bhardwaj A; Tarique M; Sharma A; Khanna N; Ramesh V; Puri P; Srivastava RK
    Cytokine; 2022 Apr; 152():155821. PubMed ID: 35151928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6.
    Saini C; Siddiqui A; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004592. PubMed ID: 27035913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated IL-6R on CD4
    Saini C; Srivastava RK; Tarique M; Kurra S; Khanna N; Ramesh V; Sharma A
    Sci Rep; 2020 Sep; 10(1):15143. PubMed ID: 32934336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy.
    Palermo ML; Pagliari C; Trindade MA; Yamashitafuji TM; Duarte AJ; Cacere CR; Benard G
    Am J Trop Med Hyg; 2012 May; 86(5):878-83. PubMed ID: 22556091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells: Friends or foe in human Mycobacterium leprae infection?
    Chaves AT; Ribeiro-Junior AF; Lyon S; Medeiros NI; Cassirer-Costa F; Paula KS; Alecrim ES; Menezes CAS; Correa-Oliveira R; Rocha MOC; Gomes JAS
    Immunobiology; 2018; 223(4-5):397-404. PubMed ID: 29150026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
    Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
    BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy.
    Chaitanya VS; Lavania M; Nigam A; Turankar RP; Singh I; Horo I; Sengupta U; Jadhav RS
    Immunol Lett; 2013; 156(1-2):159-67. PubMed ID: 24189521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction.
    Sousa AL; Fava VM; Sampaio LH; Martelli CM; Costa MB; Mira MT; Stefani MM
    J Infect Dis; 2012 May; 205(9):1417-24. PubMed ID: 22459738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box P3-positive regulatory T-cells and interleukin 17-positive T-helper 17 cells in chronic inflammatory periodontal disease.
    Parachuru VP; Coates DE; Milne TJ; Hussaini HM; Rich AM; Seymour GJ
    J Periodontal Res; 2014 Dec; 49(6):817-26. PubMed ID: 24506561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
    Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
    Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased IL-35 producing Tregs and CD19
    Tarique M; Saini C; Naqvi RA; Khanna N; Rao DN
    Cytokine; 2017 Mar; 91():82-88. PubMed ID: 28038394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
    Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
    J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.
    Liang H; Yi L; Wang X; Zhou C; Xu L
    Scand J Immunol; 2014 Aug; 80(2):144-50. PubMed ID: 24813240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.